These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 2410115
1. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP. Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [Abstract] [Full Text] [Related]
2. [Molecular biology of human T-lymphotropic retroviruses (HTLV)]. Dorner F, Barrett PN, Schmidt BL, Bodemer W. Wien Med Wochenschr; 1986 Apr 30; 136(7-8):181-8. PubMed ID: 2425498 [Abstract] [Full Text] [Related]
3. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH. Cancer Res; 1985 Sep 30; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [Abstract] [Full Text] [Related]
4. Subunit vaccines against exogenous retroviruses: overview and perspectives. Hunsmann G. Cancer Res; 1985 Sep 30; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114 [Abstract] [Full Text] [Related]
5. Molecular biology of human T-lymphotropic retroviruses. Wong-Staal F, Ratner L, Shaw G, Hahn B, Harper M, Franchini G, Gallo R. Cancer Res; 1985 Sep 30; 45(9 Suppl):4539s-4544s. PubMed ID: 2990683 [Abstract] [Full Text] [Related]
6. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses. Oroszlan S, Copeland TD, Rice NR, Smythers GW, Tsai WP, Yoshinaka Y, Shimotohno K. Princess Takamatsu Symp; 1984 Sep 30; 15():147-57. PubMed ID: 6100635 [Abstract] [Full Text] [Related]
11. Structural and epidemiological features of primate lymphotropic retroviruses. Hunsmann G, Schneider J, Bayer H, Jurkiewicz E, Yamamoto N. Princess Takamatsu Symp; 1984 Nov 15; 15():109-18. PubMed ID: 6100632 [Abstract] [Full Text] [Related]
12. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. Shaw GM, Broder S, Essex M, Gallo RC. Adv Intern Med; 1984 Nov 15; 30():1-27. PubMed ID: 6084947 [Abstract] [Full Text] [Related]
16. Variable and conserved neutralization antigens of human immunodeficiency virus. Weiss RA, Clapham PR, Weber JN, Dalgleish AG, Lasky LA, Berman PW. Nature; 1984 Nov 15; 324(6097):572-5. PubMed ID: 2431324 [Abstract] [Full Text] [Related]
17. Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys. Papas TS, Samuel KP, Kan NC, Ascione R, Wong-Staal F, Lautenberger JA. Cancer Res; 1985 Sep 15; 45(9 Suppl):4568s-4573s. PubMed ID: 2861893 [Abstract] [Full Text] [Related]
18. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS. Gallo RC. Princess Takamatsu Symp; 1984 Sep 15; 15():13-38. PubMed ID: 6100633 [Abstract] [Full Text] [Related]
20. Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope. Copeland TD, Tsai WP, Kim YD, Oroszlan S. J Immunol; 1986 Nov 01; 137(9):2945-51. PubMed ID: 2428880 [Abstract] [Full Text] [Related] Page: [Next] [New Search]